Skip to main content
Premium Trial:

Request an Annual Quote

Enzo Biochem to Enter Cytogenetics Market with Single Copy DNA Probes

NEW YORK, May 24 (GenomeWeb News) - Enzo Biochem signed a licensing agreement with Missouri-based Children's Mercy Hospitals & Clinics for cytogenetics technology, the company announced yesterday.


Terms of the deal call for Enzo to receive technology involving the application and combination of fluorescence in situ hybridization with human genome sequence information, along with rights to any future related patents. The agreement also gave Enzo rights to approximately 50 DNA probes developed at the University.


The agreement allows Enzo to enter the cytogenetics market by producing newly patented single copy DNA probes that can identify the minutest DNA. Enzo will produce the probes in its manufacturing facility in New York and market them worldwide, the company said.


The company will combine the probes with its signal amiplification technologies, which will improve visualization levels. Unlike commercially produced DNA probes, which are limited to primarily examining large sections of DNA, single copy DNA probes offer a specificity in hybridizing genetic chromosomes.


Financial details were not disclosed.

The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.